MX9300313A - Antagonistas de benzopiranos y ltb4 relacionado. - Google Patents

Antagonistas de benzopiranos y ltb4 relacionado.

Info

Publication number
MX9300313A
MX9300313A MX9300313A MX9300313A MX9300313A MX 9300313 A MX9300313 A MX 9300313A MX 9300313 A MX9300313 A MX 9300313A MX 9300313 A MX9300313 A MX 9300313A MX 9300313 A MX9300313 A MX 9300313A
Authority
MX
Mexico
Prior art keywords
benzopyran
antagonists
ltb4
substituted
formula
Prior art date
Application number
MX9300313A
Other languages
English (en)
Inventor
Sally G Ruggeri
Kevin Koch
Lawrence S Melvin Jr
Lawrence A Reiter
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9300313A publication Critical patent/MX9300313A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/13—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Benzopirano y otros antagonistas de leucotrineto B4 de anillos de benceno fusionados que tienen la fórmula en donde A, n, R1, R2, R3 son como se definen en la presente. Los compuestos de la fórmula (I) en donde R1 es CR4R5COOR13 substituido en c pueden ser preparados a partir del compuesto CF3SO3 substituido en c correspondiente mediante la reacción con un acetal de trimetilsililceteno.
MX9300313A 1992-01-23 1993-01-22 Antagonistas de benzopiranos y ltb4 relacionado. MX9300313A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82467892A 1992-01-23 1992-01-23
US89005592A 1992-05-28 1992-05-28

Publications (1)

Publication Number Publication Date
MX9300313A true MX9300313A (es) 1994-06-30

Family

ID=27124835

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300313A MX9300313A (es) 1992-01-23 1993-01-22 Antagonistas de benzopiranos y ltb4 relacionado.

Country Status (27)

Country Link
US (1) US5550152A (es)
EP (1) EP0623122B1 (es)
JP (1) JP2813464B2 (es)
KR (1) KR950700274A (es)
CN (1) CN1074681A (es)
AP (1) AP385A (es)
AT (1) ATE149493T1 (es)
AU (1) AU2773392A (es)
BG (1) BG98873A (es)
BR (1) BR9207064A (es)
CA (1) CA2117349C (es)
CZ (1) CZ395492A3 (es)
DE (1) DE69217998T2 (es)
DK (1) DK0623122T3 (es)
ES (1) ES2098547T3 (es)
FI (1) FI943473A0 (es)
GR (1) GR3022999T3 (es)
HU (1) HUT67929A (es)
IL (1) IL104421A0 (es)
IS (1) IS3968A (es)
MX (1) MX9300313A (es)
NO (1) NO942758D0 (es)
OA (1) OA10713A (es)
PT (1) PT101182A (es)
TW (1) TW213456B (es)
UY (1) UY23537A1 (es)
WO (1) WO1993015066A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
KR100232340B1 (ko) * 1994-10-13 1999-12-01 디. 제이. 우드, 스피겔 알렌 제이 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
AU696890B2 (en) * 1994-10-13 1998-09-24 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists
AU713701B2 (en) * 1996-09-16 1999-12-09 Pfizer Inc. Processes and intermediates for preparing substituted chromanol derivatives
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (en) * 1996-10-17 2000-11-29 Pfizer Inc. Method of preventing allograft rejection
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
HUP0400758A3 (en) 2000-11-03 2005-02-28 Bristol Myers Squibb Pharma Co Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
US6958156B2 (en) * 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
WO2002060888A1 (en) * 2001-01-30 2002-08-08 Pfizer Products Inc. Processes for preparing chromanylbenzoic acids
WO2006011048A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist
GEP20115239B (en) * 2006-10-31 2011-06-10 Pfizer Prod Inc Pyrazoline compounds as mineralocorticoid receptor antagonists
CN104710438B (zh) * 2013-12-11 2019-11-29 中国科学院上海药物研究所 促进iPS细胞产生的螺环类化合物及其制备方法和用途
US10849954B2 (en) * 2014-11-11 2020-12-01 Juntendo Educational Foundation Preventive or therapeutic agent for age-related macular degeneration
TW201711999A (zh) 2015-09-03 2017-04-01 佛瑪治療公司 ﹝６，６﹞稠合雙環組蛋白脫乙醯基酶８（ｈｄａｃ８）抑制劑
EP3383388B1 (en) 2015-11-30 2021-04-14 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
US20190382363A1 (en) 2015-11-30 2019-12-19 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists
EP3383389B1 (en) 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists
CN109289091B (zh) * 2018-10-09 2021-04-13 温州医科大学附属第一医院 一种用于装载骨髓间充质干细胞的复合支架及其制备方法
CN111647003B (zh) * 2020-06-08 2022-06-21 中国科学院昆明植物研究所 三环氧六氢色酮a及其药物组合物和其应用
CN111671745A (zh) * 2020-07-29 2020-09-18 北京大学 化合物在治疗溃疡性结肠炎药物制备中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
CZ395492A3 (en) 1994-03-16
JPH07503464A (ja) 1995-04-13
BG98873A (en) 1995-03-31
DE69217998T2 (de) 1997-06-12
CA2117349C (en) 2000-02-29
WO1993015066A1 (en) 1993-08-05
ATE149493T1 (de) 1997-03-15
AP9200441A0 (en) 1993-01-31
NO942758L (no) 1994-07-22
US5550152A (en) 1996-08-27
EP0623122B1 (en) 1997-03-05
OA10713A (en) 2002-12-04
IL104421A0 (en) 1993-05-13
AP385A (en) 1995-05-15
EP0623122A1 (en) 1994-11-09
PT101182A (pt) 1994-03-31
HU9402163D0 (en) 1994-09-28
HUT67929A (en) 1995-05-29
JP2813464B2 (ja) 1998-10-22
GR3022999T3 (en) 1997-07-30
KR950700274A (ko) 1995-01-16
CA2117349A1 (en) 1993-08-05
IS3968A (is) 1993-07-24
TW213456B (es) 1993-09-21
FI943473A (fi) 1994-07-22
UY23537A1 (es) 1993-06-28
FI943473A0 (fi) 1994-07-22
DE69217998D1 (de) 1997-04-10
BR9207064A (pt) 1995-12-19
ES2098547T3 (es) 1997-05-01
AU2773392A (en) 1993-09-01
DK0623122T3 (da) 1997-04-21
NO942758D0 (no) 1994-07-22
CN1074681A (zh) 1993-07-28

Similar Documents

Publication Publication Date Title
MX9300313A (es) Antagonistas de benzopiranos y ltb4 relacionado.
ES2094991T3 (es) Derivados de alquenos.
DK0403809T4 (da) Chemiluminiscerende opløsning baseret på substitueret perylen
ES2140181T3 (es) Androstenonas.
FI823338A0 (fi) Foerfarande och mellanprodukt foer framstaellning av 7-brom-5-(2-halogenfenyl)-1h-2,3-dihydro-1,4-benzodiazepin-foereningar
TR22986A (tr) Halka hetero atomlari haiz bisiklo-heptanlar,oktanlar ve nonanlar,bunlarin hazirlanmasi ve pestibid olarak kullanimlari
ES2088270T3 (es) Derivados alquilicos de la trazodona provistos de actividad sobre el sistema nervioso central.
ATE190334T1 (de) Azlacton-derivatisierte polyamide
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
ATE298254T1 (de) Chelatisierungsmitteln
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
SE7503522L (sv) Cyklohexenylforeningar.
ATE18922T1 (de) Texturiertes nylon-6 filament.
GB8400441D0 (en) Quinazolines
ES2174390T3 (es) Eteres cicloalquilicos y composiciones perfumantes que los contienen.
ES2150810T3 (es) Compuestos aromaticos sustituidos con benciloxi y su uso como fungicidas e insecticidas.
JPS6440593A (en) Photochromic composition
SU1690242A1 (ru) Антифидант
TH9316EX (th) อนุพันธ์ต่างๆ ของ 2- ออกโซ -1- ออกซา -8- อะซาสไพโร [4,5] เดเคนชนิดใหม่, สารผสมทางเภสัชกรรมที่มีสารประกอบพวกนี้และกรรมวิธีสำหรับการเตรียมสารประกอบชนิดเดียวกันนี้
TH9316A (th) อนุพันธ์ต่างๆ ของ 2- ออกโซ -1- ออกซา -8- อะซาสไพโร [4,5] เดเคนชนิดใหม่, สารผสมทางเภสัชกรรมที่มีสารประกอบพวกนี้และกรรมวิธีสำหรับการเตรียมสารประกอบชนิดเดียวกันนี้
DE68910253D1 (de) Substituierte Imidazo[2,1-b]chinazolin-5(3H)-one und entsprechende tricyclische Verbindungen.
MX9303555A (es) Derivados de quinoxalina, su preparacion y uso en medicamentos.